ARCHIVES

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

This article is from The Cancer Letter archive.

Vol. 18 No. 20 | May 15, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997